跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OBUTIN TABLETS 5 mg - HSA Drug Approval Details
Approvals
/
HSA
/
OBUTIN TABLETS 5 mg
Approved
THERAPEUTIC
OBUTIN TABLETS 5 mg
HANLIM PHARMACEUTICAL CO LTD
🇸🇬 Health Sciences Authority
Approval Date
Nov 4, 1999
Approval ID
a0a8b531c1a54c51
Company
HANLIM PHARMACEUTICAL CO LTD
Type
Therapeutic
Approval Details
Approval Id
a0a8b531c1a54c51
Drug Name
OBUTIN TABLETS 5 mg
Product Name
OBUTIN TABLETS 5 mg
Approval Number
SIN11215P
Approval Date
1999-11-04
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
G04BD04
Atc Item Name
oxybutynin
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
OXYBUTYNIN CHLORIDE
5 mg
OXYBUTYNIN CHLORIDE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 4, 1999
Approval ID
a0a8b531c1a54c51
Type
Therapeutic
Back to HSA Approvals